Laura Faivre

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value

Francesco Facchinetti, M.V. Bluthgen, Gabrielle Tergemina-Clain et al. · Lung Cancer · 2017 · 110 citations

Somatic Variant, Lkb1/stk11 Mutations, Medicine +9

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma

Julien Adam, Émilie Louvet, Tony Sourisseau et al. · ESMO Open · 2018 · 89 citations · Full text

Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.

Denis Moro‐Sibilot, Laura Faivre, Gérard Zalcman et al. · Journal of Clinical Oncology · 2015 · 47 citations

Pathology, Crz 250, Oncology +16

Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab

Yungan Tao, Laura Faivre, Anne Laprie et al. · Radiotherapy and Oncology · 2018 · 40 citations

Salvage Surgery, Surgical Oncology, Daily Split-course Radiotherapy +9

Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography

Nathalie Lassau, B Coiffier, Laura Faivre et al. · Investigative Radiology · 2017 · 28 citations